LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH L impact Sep 28, 2026, 04:16 PM UTC

Capital Fund Management discloses 1.19% net short position in Atos Group

The position was disclosed as of 2026-09-25.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

ATOS.PA

Related stories

Revolution Medicines Starts Phase 3 Trial for Pancreatic Cancer Drug Revolution Medicines has begun treating patients in its Phase 3 RASolute 309 trial for its drug daraxonrasib (RASONQUE™) combined with zoldonrasib. The trial is evaluating the comb M impact | EQUITY | Oct 05, 2026, 12:09 PM UTC Big cap premarket movers on Brazil, PCVX, PTC Brazil names traded higher after Bolsonaro beat expectations in the presidential vote. PCVX rose on positive topline data from OPUS-1, while PTC gained after news it will be acquir M impact | EQUITY | Oct 05, 2026, 12:09 PM UTC Qualcomm Secures Multi-Year Huawei Patent Licensing Deal Qualcomm and Huawei have entered a multi-year patent licensing arrangement covering 5G, computing, artificial intelligence, and networking technologies. As part of the deal, Qualco M impact | EQUITY | Oct 05, 2026, 12:08 PM UTC GE Healthcare Acquires Sofie Biosciences to Expand Radiopharmaceutical Footprint GE HealthCare Technologies Inc. (GEHC) has announced its acquisition of Sofie Biosciences, a move aimed at establishing a 'final mile' footprint for radiopharmaceutical supply in t M impact | EQUITY | Oct 05, 2026, 12:06 PM UTC Roche Licenses Parkinson's Therapy From Alector For Up To $1.27B Swiss drugmaker Roche will pay up to $1.27 billion to license Alector's experimental Parkinson's disease treatment. Alector will receive $100 million upfront and potential future p M impact | EQUITY | Oct 05, 2026, 12:06 PM UTC Wells Fargo to announce third-quarter 2026 earnings on Oct. 13 Wells Fargo said it will announce third-quarter 2026 earnings on Oct. 13, 2026. M impact | EQUITY | Oct 05, 2026, 12:05 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.